INNOGENE Co.,Ltd. (KOSDAQ:344860)
1,335.00
-11.00 (-0.82%)
At close: Jul 21, 2026
INNOGENE Market Cap
INNOGENE has a market cap or net worth of 16.06 billion as of July 22, 2026. Its market cap has decreased by -35.19% in one year.
Market Cap
16.06B
Enterprise Value
6.80B
Revenue
9.04B
Ranking
n/a
PE Ratio
102.03
Stock Price
1,335.00
ChartMarket Cap Chart
Since April 27, 2020, INNOGENE's market cap has increased from 9.45B to 16.06B, an increase of 70.01%. That is a compound annual growth rate of 8.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 16.06B | -28.38% |
| Dec 30, 2025 | 22.42B | 25.86% |
| Dec 30, 2024 | 17.82B | -45.95% |
| Dec 28, 2023 | 32.96B | -19.53% |
| Dec 29, 2022 | 40.96B | -2.00% |
| Dec 30, 2021 | 41.80B | 1,851.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outin Futures | 25.69B |
| Csa Cosmic | 24.07B |
| SR biotek | 23.64B |
| TS Trillion | 23.40B |
| Ha U Dong Chun | 22.56B |
| Nord Mason | 21.44B |
| INSAN | 20.58B |
| Medience | 20.40B |